{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:53:35Z","timestamp":1793159615206,"version":"4.5.0"},"reference-count":125,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2017.00030","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T03:52:46Z","timestamp":1486007566000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":177,"title":["Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target"],"prefix":"10.3389","volume":"11","author":[{"given":"Tommaso","family":"Cassano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Calcagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Pace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Gaetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.intimp.2011.05.006","article-title":"Toll-like receptors are key players in neurodegeneration","volume":"11","author":"Arroyo","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/jnr.23318","article-title":"5-S-cysteinyldopamine neurotoxicity: influence on the expression of \u03b1-synuclein and ERp57 in cellular and animal models of Parkinson's disease","volume":"92","author":"Aureli","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1523\/JNEUROSCI.1799-06.2006","article-title":"Alpha-synuclein expression modulates microglial activation phenotype","volume":"26","author":"Austin","year":"2006","journal-title":"J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cortex.2008.11.010","article-title":"Parkinson's disease: the syndrome, the pathogenesis and pathophysiology","volume":"45","author":"Bartels","year":"2009","journal-title":"Cortex"},{"key":"B5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3233\/JAD-141635","article-title":"The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease","volume":"43","author":"Bedse","year":"2015","journal-title":"J. Alzheimers. Dis."},{"key":"B7","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bjp.0707505","article-title":"Cannabinoid CB2 receptors in human brain inflammation","volume":"153","author":"Benito","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2003.09.001","article-title":"Molecular regulation of CD40 gene expression in macrophages and microglia","volume":"18","author":"Benveniste","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.14336\/AD.2015.0617","article-title":"Potential therapeutical contributions of the endocannabinoid system towards aging and Alzheimer's disease","volume":"6","author":"Bonnet","year":"2015","journal-title":"Aging Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bbr.2009.11.020","article-title":"Striatal 6-OHDA lesion in mice: investigating early neurochemical changes underlying Parkinson's disease","volume":"208","author":"Branchi","year":"2010","journal-title":"Behav. Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/jnr.21642","article-title":"Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model","volume":"86","author":"Branchi","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0167-4781(02)00341-X","article-title":"Cloning and molecular characterization of the rat CB2 cannabinoid receptor","volume":"1576","author":"Brown","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"B14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1017\/S1462399409000957","article-title":"Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation","volume":"11","author":"Cabral","year":"2009","journal-title":"Expert. Rev. Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"20851","DOI":"10.1074\/jbc.M111.335273","article-title":"Cannabinoid receptors CB1 and CB2 form functional heteromers in brain","volume":"287","author":"Call\u00e9n","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S1474-4422(05)70026-0","article-title":"Treatment for the progression of Parkinson's disease","volume":"4","author":"Calne","year":"2005","journal-title":"Lancet Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1212\/01.WNL.0000140288.48796.8E","article-title":"Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study","volume":"63","author":"Carroll","year":"2004","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2174\/1567205013666151218132725","article-title":"Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration","volume":"13","author":"Cassano","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.neurobiolaging.2011.09.021","article-title":"Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease","volume":"33","author":"Cassano","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/156720510791050948","article-title":"Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model","volume":"7","author":"Chen","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2174\/156802606776743057","article-title":"Tau therapeutic strategies for the treatment of Alzheimer's disease","volume":"6","author":"Churcher","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neubiorev.2014.08.008","article-title":"Endocannabinoid signaling and food addiction","volume":"47","author":"D'Addario","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijpharm.2012.08.023","article-title":"Novel codrugs with GABAergic activity for dopamine delivery in the brain","volume":"437","author":"Denora","year":"2012","journal-title":"Int. J. Pharm."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejpb.2015.05.019","article-title":"Intranasal delivery of dopamine to the striatum using glycol chitosan\/sulfobutylether-\u03b2-cyclodextrin based nanoparticles","volume":"94","author":"Di Gioia","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5812\/ijhrba.9222","article-title":"The endocannabinoid system: a putative role in neurodegenerative diseases","volume":"2","author":"Di Iorio","year":"2013","journal-title":"Int. J. High Risk Behav. Addict."},{"key":"B30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0009-3084(02)00150-0","article-title":"A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation","volume":"121","author":"Dinh","year":"2002","journal-title":"Chem. Phys. Lipids."},{"key":"B32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2047-9158-1-24","article-title":"Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration","volume":"1","author":"Duan","year":"2012","journal-title":"Transl. Neurodegener."},{"key":"B33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0306-4522(03)00145-3","article-title":"Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling","volume":"119","author":"Egertov\u00e1","year":"2003","journal-title":"Neuroscience"},{"key":"B34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflammation."},{"key":"B35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/3-540-26573-2_9","article-title":"The phylogenetic distribution and evolutionary origins of endocannabinoid signalling","volume":"168","author":"Elphick","year":"2005","journal-title":"Handb. Exp. Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1124\/jpet.107.121566","article-title":"Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence","volume":"322","author":"Esposito","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/bph.12492","article-title":"The influence of cannabinoids on generic traits of neurodegeneration","volume":"171","author":"Fagan","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.neuropharm.2012.05.013","article-title":"WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-\u03b3 pathway","volume":"63","author":"Fakhfouri","year":"2012","journal-title":"Neuropharmacology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1517\/14728221003709792","article-title":"The endocannabinoid system as a target for the treatment of neuronal damage","volume":"14","author":"Fern\u00e1ndez-Ruiz","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"B40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s13311-015-0381-7","article-title":"Cannabinoids in neurodegenerative disorders and stroke\/brain trauma: from preclinical models to clinical applications","volume":"12","author":"Fern\u00e1ndez-Ruiz","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/j.1476-5381.2011.01278.x","article-title":"Symptom-relieving and neuroprotective effects of the phytocannabinoid \u03949-THCV in animal models of Parkinson's disease","volume":"163","author":"Garc\u00eda","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-3-211-92660-4_22","article-title":"Cannabinoid CB1 receptors are early downregulated followed by a further upregulation in the basal ganglia of mice with deletion of specific park genes","volume":"73","author":"Garc\u00eda-Arencibia","year":"2009","journal-title":"J. Neural. Transm. Suppl."},{"key":"B45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoids receptor-independent properties","volume":"1134","author":"Garc\u00eda-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2015.03.017","article-title":"Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease","volume":"64","author":"G\u00f3mez-G\u00e1lvez","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B48","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0022-3565(24)35367-4","article-title":"Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor","volume":"292","author":"Griffin","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B49","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3233\/JAD-2009-0996","article-title":"Gene expression as peripheral biomarkers for sporadic Alzheimer's disease","volume":"16","author":"Gr\u00fcnblatt","year":"2009","journal-title":"J. Alzheimers. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/glia.21081","article-title":"WNT signaling in activated microglia is proinflammatory","volume":"59","author":"Halleskog","year":"2011","journal-title":"Glia"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson's disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1016\/j.bmc.2010.05.058","article-title":"Synthesis and biodistribution of [11C]A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)","volume":"18","author":"Horti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"B54","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neures.2008.04.011","article-title":"The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: implications in Parkinson's disease","volume":"61","author":"Jimenez-Del-Rio","year":"2008","journal-title":"Neurosci. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.brainres.2010.12.061","article-title":"Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe\/PS1\u0394E9 double transgenic mice","volume":"1376","author":"Kalifa","year":"2011","journal-title":"Brain Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjp.0705304","article-title":"Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor","volume":"139","author":"Klegeris","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2006.11.013","article-title":"Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia","volume":"29","author":"Klegeris","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"B58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1189\/jlb.0303101","article-title":"The cannabinoid system and immune modulation","volume":"74","author":"Klein","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat. Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1046\/j.0953-816x.2001.01812.x","article-title":"Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets","volume":"14","author":"Lastres-Becker","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1601-183X.2009.00498.x","article-title":"Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands","volume":"8","author":"Liu","year":"2009","journal-title":"Genes Brain Behav."},{"key":"B62","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B63","first-page":"53","article-title":"Endogenous cannabinoids in neuronal and immune cells: toxic effects, levels and degradation","volume":"16","author":"Maccarrone","year":"2001","journal-title":"Funct. Neurol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.tibs.2010.05.008","article-title":"Intracellular trafficking of anandamide: new concepts for signaling","volume":"35","author":"Maccarrone","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"B65","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","volume":"168","author":"Mackie","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3233\/JAD-140492","article-title":"Type-1 cannabinoid receptor activity during Alzheimer's disease progression","volume":"42","author":"Manuel","year":"2014","journal-title":"J. Alzheimers. Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"J. Neurochem."},{"key":"B68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Martin-Moreno","year":"2012","journal-title":"J. Neuroinflammation."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-7091-6781-6_8","article-title":"Alzheimer disease and neuroinflammation","volume":"59","author":"McGeer","year":"2000","journal-title":"J. Neural Transm. Suppl."},{"key":"B71","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/cne.1078","article-title":"Cannabinoid receptors are absent in insects","volume":"436","author":"McPartland","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1126\/science.168.3936.1159","article-title":"Marihuana chemistry","volume":"168","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"B74","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.bjp.0706415","article-title":"Plant cannabinoids: a neglected pharmacological treasure trove","volume":"146","author":"Mechoulam","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1021\/ja01092a065","article-title":"A total synthesis of DL-delta-1-tetrahydrocannabinol, the active constituent of hashish","volume":"87","author":"Mechoulam","year":"1965","journal-title":"J. Am. Chem. Soc."},{"key":"B77","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"B79","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/jnr.10165","article-title":"Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures","volume":"67","author":"Molina-Holgado","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"B80","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1523\/JNEUROSCI.23-16-06470.2003","article-title":"Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia","volume":"23","author":"Molina-Holgado","year":"2003","journal-title":"J. Neurosci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.expneurol.2007.07.021","article-title":"Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors","volume":"208","author":"Morgese","year":"2007","journal-title":"Exp. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuint.2008.10.007","article-title":"Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2","volume":"54","author":"Morgese","year":"2009","journal-title":"Neurochem. Int."},{"issue":"Pt 4","key":"B83","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer's disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain"},{"key":"B84","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.neuropharm.2009.11.010","article-title":"Targeting p38 MAPK pathway for the treatment of Alzheimer's disease","volume":"58","author":"Munoz","year":"2010","journal-title":"Neuropharmacology"},{"key":"B85","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/0-306-47611-8_27","article-title":"CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types","volume":"493","author":"Nong","year":"2001","journal-title":"Adv. Exp. Med. Biol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/syn.20050","article-title":"Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study","volume":"53","author":"N\u00fa\u00f1ez","year":"2004","journal-title":"Synapse"},{"key":"B87","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroscience.2007.10.029","article-title":"Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome","volume":"151","author":"N\u00fa\u00f1ez","year":"2008","journal-title":"Neuroscience"},{"key":"B88","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"29","author":"Price","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ram\u00edrez","year":"2005","journal-title":"J. Neurosci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1523\/JNEUROSCI.3158-09.2009","article-title":"CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation","volume":"29","author":"Reed-Geaghan","year":"2009","journal-title":"J. Neurosci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1111\/j.1471-4159.2007.05087.x","article-title":"Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease","volume":"104","author":"Reynolds","year":"2007","journal-title":"J. Neurochem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11481-008-9100-z","article-title":"Nitrated alpha-synuclein and microglial neuroregulatory activities","volume":"3","author":"Reynolds","year":"2008","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/bph.12283","article-title":"Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias","volume":"171","author":"Rodr\u00edguez-Cueto","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10495-010-0463-2","article-title":"The role of caspases in Alzheimer's disease; potential novel therapeutic opportunities","volume":"15","author":"Rohn","year":"2010","journal-title":"Apoptosis"},{"key":"B98","first-page":"S7","article-title":"Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?","volume":"32","author":"Saito","year":"2010","journal-title":"Revista Brasileira de Psiquiatria"},{"key":"B99","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clim.2011.02.010","article-title":"Neuroprotective agents: cannabinoids","volume":"142","author":"S\u00e1nchez","year":"2012","journal-title":"Clin. Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.2174\/138161211796904740","article-title":"Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases","volume":"17","author":"Serviddio","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"B102","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/glia.20108","article-title":"Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes","volume":"49","author":"Sheng","year":"2005","journal-title":"Glia"},{"key":"B103","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0167-4781(96)00047-4","article-title":"Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor","volume":"1307","author":"Shire","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"B104","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.neurobiolaging.2012.06.005","article-title":"CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients","volume":"34","author":"Solas","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B105","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.biochi.2006.07.019","article-title":"Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol","volume":"88","author":"Spoto","year":"2006","journal-title":"Biochimie"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/glia.20983","article-title":"Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas","volume":"58","author":"Stella","year":"2010","journal-title":"Glia"},{"key":"B108","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B110","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.neuint.2012.12.016","article-title":"Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease","volume":"62","author":"Taylor","year":"2013","journal-title":"Neurochem. Int."},{"key":"B112","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neurobiolaging.2010.09.012","article-title":"Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine","volume":"33","author":"Ternianov","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"B113","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1471-4159.2006.04315.x","article-title":"Ion channel blockade attenuates aggregated alpha synuclein induction of microglial reactive oxygen species: relevance for the pathogenesis of Parkinson's disease","volume":"100","author":"Thomas","year":"2007","journal-title":"J. Neurochem."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ijpharm.2011.07.036","article-title":"Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery","volume":"419","author":"Trapani","year":"2011","journal-title":"Int. J. Pharm."},{"key":"B115","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-016-2300-4","article-title":"The CB(2) receptor and its role as a regulator of inflammation","volume":"73","author":"Turcotte","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"B116","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"B117","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/s12017-014-8314-x","article-title":"Functions of the CB1 and CB2 receptors in neuroprotection at the level of the blood-brain barrier","volume":"16","author":"Vendel","year":"2014","journal-title":"Neuromol. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1523\/JNEUROSCI.0786-09.2009","article-title":"Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K\/Akt pathway","volume":"29","author":"Viscomi","year":"2009","journal-title":"J. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"B120","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.nbd.2004.12.013","article-title":"Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation","volume":"18","author":"White","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"B121","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2005.06.009","article-title":"Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons","volume":"135","author":"Wotherspoon","year":"2005","journal-title":"Neuroscience"},{"key":"B122","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1471-2377-6-12","article-title":"COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells\/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord","volume":"6","author":"Yiangou","year":"2006","journal-title":"BMC Neurol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","article-title":"Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00030\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:55:31Z","timestamp":1749941731000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fnins.2017.00030\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":125,"URL":"https:\/\/doi.org\/10.3389\/fnins.2017.00030","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}